Acceder

Bibliografías temáticas / Small Cell Lung Cancer / Artículos de revistas

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Small Cell Lung Cancer.

Artículos de revistas sobre el tema "Small Cell Lung Cancer"

Autor: Grafiati

Publicado: 4 de junio de 2021

Última modificación: 25 de julio de 2025

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Small Cell Lung Cancer".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Greschuchna, D. "Surgical Treatment of Small Cell Lung Cancer." Journal of the Japanese Association for Chest Surgery 3, no. 2 (1989): 169. http://dx.doi.org/10.2995/jacsurg1987.3.2_169.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

2

Skenduli, Ilir, and Perlat Kapisyzi. "Surgery for Non Small Cell Lung Cancer - A Systematic Review." International Journal of Science and Research (IJSR) 11, no. 5 (2022): 1551–56. http://dx.doi.org/10.21275/sr22518021202.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

3

_, _. "Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 6, no. 3 (2008): 294. http://dx.doi.org/10.6004/jnccn.2008.0025.

Texto completo

Resumen

Small cell lung cancer (SCLC) accounts for 15% of lung cancers. Nearly all cases of SCLC are attributable to cigarette smoking, and the remaining cases are presumably caused by environmental or genetic factors. Compared with non-small cell lung cancer, SCLC generally has a more rapid doubling time, a higher growth fraction, and earlier development of widespread metastases. SCLC is highly sensitive to initial chemotherapy and radiotherapy, but most patients eventually die from recurrent disease. These guidelines detail the management of SCLC from initial diagnosis and staging through treatment,

Los estilos APA, Harvard, Vancouver, ISO, etc.

4

Hellriegel, H. "ADVANCED NON-SMALL-CELL LUNG CANCER. THE SIGNIFICANCE OF PERSONALIZED THERAPY." Siberian Medical Review, no. 6 (2017): 6–12. http://dx.doi.org/10.20333/2500136-2017-6-12.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

5

Klaus-Peter, K. "ADVANCED NON-SMALL-CELL LUNG CANCER. THE SIGNIFICANCE OF PERSONALIZED THERAPY." Siberian Medical Review, no. 6 (2017): 6–12. http://dx.doi.org/10.20333/2500136-2017-6-6-12.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

6

Kammaev, K. A. "Non-small cell lung carcinoma. Clinical case." Filin’s Clinical endoscopy 66, no. 3 (2024): 62–65. http://dx.doi.org/10.31146/2415-7813-endo-66-3-62-65.

Texto completo

Resumen

In 2020, 2.2 million new cases of lung cancer were reported. The main form of lung cancer is non-small cell carcinoma (85%). Non-small cell lung cancer has 3 subtypes: adenocarcinoma, large cell and squamous cell carcinoma. Squamous cell lung cancer occurs in 20-40% of all lung cancers. Squamous cell lung cancer is associated with an unfavorable outcome. 5-year survival rate not exceeding 18%.

Los estilos APA, Harvard, Vancouver, ISO, etc.

7

Kalemkerian, Gregory P., Wallace Akerley, Paul Bogner, et al. "Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 9, no. 10 (2011): 1086–113. http://dx.doi.org/10.6004/jnccn.2011.0092.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

8

Kalemkerian, Gregory P., Wallace Akerley, Paul Bogner, et al. "Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 11, no. 1 (2013): 78–98. http://dx.doi.org/10.6004/jnccn.2013.0011.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

9

Byrne, Bernadette. "Small cell lung cancer." Nursing Standard 8, no. 9 (1993): 23–28. http://dx.doi.org/10.7748/ns.8.9.23.s42.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

10

Hinson, J. A., and M. C. Perry. "Small cell lung cancer." CA: A Cancer Journal for Clinicians 43, no. 4 (1993): 216–25. http://dx.doi.org/10.3322/canjclin.43.4.216.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

11

Bakhmutsky, Nicolay G., Vladimir A. Porkhanov, Vadim N. Bodnya, and Rostislav P. Schiryayev. "Small-cell lung cancer." Medical Herald of the South of Russia 8, no. 4 (2017): 6–13. http://dx.doi.org/10.21886/2219-8075-2017-8-4-6-13.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

12

Sher, Taimur, Grace K. Dy, and Alex A. Adjei. "Small Cell Lung Cancer." Mayo Clinic Proceedings 83, no. 3 (2008): 355–67. http://dx.doi.org/10.4065/83.3.355.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

13

&NA;. "Small-Cell Lung Cancer." Oncology Times 26, no. 19 (2004): 23. http://dx.doi.org/10.1097/01.cot.0000292340.59988.2c.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

14

McVie, J. G., O. B. Dalesio, and H. van Tinteren. "Small Cell Lung Cancer." Acta Oncologica 28, no. 5 (1989): 729–41. http://dx.doi.org/10.3109/02841868909092304.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

15

Crompton, G. "Small cell lung cancer." BMJ 300, no. 6719 (1990): 209–10. http://dx.doi.org/10.1136/bmj.300.6719.209.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

16

Sheppard, M. N. "Small cell lung cancer." BMJ 300, no. 6723 (1990): 535. http://dx.doi.org/10.1136/bmj.300.6723.535-b.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

17

Rosti, G., G. Bevilacqua, P. Bidoli, L. Portalone, A. Santo, and G. Genestreti. "Small cell lung cancer." Annals of Oncology 17 (April 2006): ii5—ii10. http://dx.doi.org/10.1093/annonc/mdj910.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

18

&NA;. "Small cell lung cancer." Inpharma Weekly &NA;, no. 838 (1992): 10. http://dx.doi.org/10.2165/00128413-199208380-00015.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

19

Haque, Niaz, Amer Raza, Robin McGoey, Brian Boulmay, Lisa Diethelm, and Stephen Kantrow. "Small Cell Lung Cancer." Southern Medical Journal 105, no. 8 (2012): 418–23. http://dx.doi.org/10.1097/smj.0b013e3182601198.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

20

Eisen, Tim, Tamas Hickish, I. E. Smith, John Sloane, and Suzanne Eccles. "Small-cell lung cancer." Lancet 345, no. 8960 (1995): 1285–89. http://dx.doi.org/10.1016/s0140-6736(95)90930-3.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

21

Simon, George R., and Henry Wagner. "Small Cell Lung Cancer*." Chest 123, no. 1 (2003): 259S—271S. http://dx.doi.org/10.1378/chest.123.1_suppl.259s.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

22

Postmus, Pieter E. "Small-cell lung cancer." Lung Cancer 77 (June 2012): S19—S20. http://dx.doi.org/10.1016/j.lungcan.2012.05.098.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

23

Berendsen, H. H., L. de Leij, P. E. Postmus, et al. "Small Cell Lung Cancer." Chest 91, no. 3 (1987): 11s—12s. http://dx.doi.org/10.1378/chest.91.3_supplement.11s.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

24

Ihde, D., B. Souhami, R. Comis, et al. "Small cell lung cancer." Lung Cancer 17 (June 1997): S19—S21. http://dx.doi.org/10.1016/s0169-5002(97)00039-1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

25

Jackman, David M., and Bruce E. Johnson. "Small-cell lung cancer." Lancet 366, no. 9494 (2005): 1385–96. http://dx.doi.org/10.1016/s0140-6736(05)67569-1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

26

Ploner, F. "Small cell lung cancer." memo - Magazine of European Medical Oncology 1, no. 4 (2008): 243–45. http://dx.doi.org/10.1007/s12254-008-0067-5.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

27

Goodman, Gary R., and Robert B. Livingston. "Small cell lung cancer." Disease-a-Month 35, no. 12 (1989): 774–825. http://dx.doi.org/10.1016/0011-5029(89)90023-0.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

28

Livingston, Robert, and Gary E. Goodman. "Small cell lung cancer." Current Problems in Cancer 13, no. 1 (1989): 7–54. http://dx.doi.org/10.1016/0147-0272(89)90014-7.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

29

Leonard, RCF. "Small cell lung cancer." British Journal of Cancer 59, no. 4 (1989): 487–90. http://dx.doi.org/10.1038/bjc.1989.101.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

30

van Meerbeeck, Jan P., Dean A. Fennell, and Dirk KM De Ruysscher. "Small-cell lung cancer." Lancet 378, no. 9804 (2011): 1741–55. http://dx.doi.org/10.1016/s0140-6736(11)60165-7.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

31

Elias, Anthony D. "Small Cell Lung Cancer." Chest 112, no. 4 (1997): 251S—258S. http://dx.doi.org/10.1378/chest.112.4_supplement.251s.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

32

Kalemkerian, Gregory. "Small Cell Lung Cancer." Seminars in Respiratory and Critical Care Medicine 37, no. 05 (2016): 783–96. http://dx.doi.org/10.1055/s-0036-1592116.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

33

O'Donnell, Walter J. "Small Cell Lung Cancer." Chest 107, no. 6 (1995): 241S—242S. http://dx.doi.org/10.1378/chest.107.6_supplement.241s.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

34

Ihde, Daniel C. "Small Cell Lung Cancer." Chest 107, no. 6 (1995): 243S—248S. http://dx.doi.org/10.1378/chest.107.6_supplement.243s.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

35

Simon, George, Robert J. Ginsberg, and John C. Ruckdeschel. "Small-Cell Lung Cancer." Chest Surgery Clinics of North America 11, no. 1 (2001): 165–88. https://doi.org/10.1016/s1052-3359(25)00558-7.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

36

Kurata, Takayasu, Isamu Okamoto, Kenji Tamura, and Masahiro Fukuoka. "Amrubicin for non-small-cell lung cancer and small-cell lung cancer." Investigational New Drugs 25, no. 5 (2007): 499–504. http://dx.doi.org/10.1007/s10637-007-9069-0.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

37

Bhargav, Manjunath Hegde, Ganapati Hegde Mahesh, Channappagol Chetan, and P. Dayananda. "Review on Deep Learning Technique for Detecting Non-Small Cell Lung Cancer." Journal of Information Technology and Sciences 5, no. 3 (2019): 15–20. https://doi.org/10.5281/zenodo.3377126.

Texto completo

Resumen

<em>The lung cancer is one of the major cancers in the world. Almost 80% of cancer we found in the world is related to lung only. We can find two different lung cancers; there are small cell lung cancer and non-small cell lung cancer. Here, we are only concentrated about the non-small cell lung cancer or (NSCLC). Here, we considered the KRAS mutation of the human gene. The KRAS biomarker is one of the main reasons for the NSCLC. Nearly 25% of the mutations happen in the form of KRAS mutation. Here, we have reviewed different deep learning and machine learning methods like convolutional neural

Los estilos APA, Harvard, Vancouver, ISO, etc.

38

Sankar, V., R. Kothai, and N. Vanisr. "Lung Cancer - A Review." International Journal of Health Sciences and Research 13, no. 10 (2023): 307–15. http://dx.doi.org/10.52403/ijhsr.20231042.

Texto completo

Resumen

Lung cancer is the prime cause of cancer death among both men and women according to WHO report 2.09 million cases globally. It is also the chief cause of cancer death among men and the second leading cause of cancer death among women worldwide. The lung cancer classified into two different types are small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC). Non-small cell lung cancer is more common than small cell lung cancer. Treatment of lung cancer may involve a combination of surgery, chemotherapy, targeted therapy, immunotherapy, and radiation therapy. Therapeutic recommenda

Los estilos APA, Harvard, Vancouver, ISO, etc.

39

Kalkan, Fatih, and Mehmet Özler. "DELTA-9 TETRAHYDROCANNABINOID AND GEMSITABIN COMBINATION ON NON-SMALL CELL (SQUAMOUS CELL, SK-MES-1) LUNG CANCER CELL LINE." Era's Journal of Medical Research 10, no. 01 (2023): 1–12. http://dx.doi.org/10.24041/ejmr2023.1.

Texto completo

Resumen

Squamous cell carcinoma falls within the category of non-small cell lung cancers, presenting a considerable challenge in terms of treatment management. There has been growing interest in the potential anti-cancer properties of Delta-9 tetrahydrocannabinol. Gemcitabine, a nucleoside analog, has shown effectiveness against diverse cancer types. This study aimed to assess the combined efficacy of Delta-9 tetrahydrocannabinol and Gemcitabine in treating cancer. The squamous lung cancer cell line required for our study was provided by the stem cell unit. The doses were determined as 5µm/L and 10µm/

Los estilos APA, Harvard, Vancouver, ISO, etc.

40

Nakanishi, Yoichi. "Chemotherapy for Lung Cancer (Small-cell Lung Cancer)." Haigan 56, no. 1 (2016): 43–47. http://dx.doi.org/10.2482/haigan.56.43.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

41

_, _. "Non–Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 6, no. 3 (2008): 228. http://dx.doi.org/10.6004/jnccn.2008.0021.

Texto completo

Resumen

Lung cancer is the leading cause of cancer-related death in both men and women in the United States. An estimated 213,380 new cases (114,760 men and 98,620 women) of lung and bronchus cancer will be diagnosed in 2007, and 160,390 deaths (89,510 in men, 70,880 in women) are estimated to occur because of the disease. Non-small cell lung cancer (NSCLC) accounts for 80% to 85% of all lung cancer cases and includes 3 major types: (1) adenocarcinoma; (2) squamous cell (epidermoid) carcinoma; and (3) large-cell carcinoma. Adenocarcinoma is the most common type of lung cancer seen in the United States

Los estilos APA, Harvard, Vancouver, ISO, etc.

42

End, A. "Diagnosis and treatment of lung cancer – Non-small cell lung cancer, small cell lung cancer and carcinoids." European Surgery 38, no. 1 (2006): 45–53. http://dx.doi.org/10.1007/s10353-006-0209-0.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

43

Ross, Mitchell D., Sreeja Biswas Roy, Pradnya D. Patil, et al. "Coexistent Non–Small Cell Carcinoma and Small Cell Carcinoma in a Patient Presenting with Hyponatremia." Case Reports in Pulmonology 2018 (2018): 1–4. http://dx.doi.org/10.1155/2018/1718326.

Texto completo

Resumen

Despite recent advances in screening methods, lung cancer remains the leading cause of cancer-related deaths worldwide. By the time lung cancer becomes symptomatic and patients seek treatment, it is often too advanced for curative measures. Low-dose computed tomography (CT) screening has been shown to reduce mortality in patients at high risk of lung cancer. We present a 66-year-old man with a 50-pack-year smoking history who had a right upper lobe (RUL) pulmonary nodule and left lower lobe (LLL) consolidation on a screening CT. He reported a weight loss of 45 pounds over 3 months, had recentl

Los estilos APA, Harvard, Vancouver, ISO, etc.

44

Deniz, Özdemir. "KAN0438757: A NOVEL PFKFB3 INHIBITOR THAT INDUCES PROGRAMMED CELL DEATH AND SUPPRESSES CELL MIGRATION IN NON-SMALL CELL LUNG CARCINOMA CELLS." Biotechnologia Acta 16, no. 5 (2023): 34–44. http://dx.doi.org/10.15407/biotech16.05.034.

Texto completo

Resumen

Aim. PFKFB3 is glycolytic activators that is overexpressed in human lung cancer and plays a crucial role in multiple cellular functions including programmed cell death. Despite the many small molecules described as PFKFB3 inhibitors, some of them have shown disappointing results in vitro and in vivo. On the other hand KAN0438757, selective and potent, small molecule inhibitor has been developed. However, the effects of KAN0438757, in non-small cell lung carcinoma cells remain unknown. Herein, we sought to decipher the effect of KAN0438757 on proliferation, migration, DNA damage, and programmed

Los estilos APA, Harvard, Vancouver, ISO, etc.

45

Skřičková, Jana, Bohdan Kadlec, and Ondřej Venclíček. "Non-small cell lung cancer." Vnitřní lékařství 63, no. 11 (2017): 861–74. http://dx.doi.org/10.36290/vnl.2017.159.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

46

Ettinger, David S., Wallace Akerley, Gerold Bepler, et al. "Non–Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 8, no. 7 (2010): 740–801. http://dx.doi.org/10.6004/jnccn.2010.0056.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

47

Ettinger, David S., Wallace Akerley, Hossein Borghaei, et al. "Non–Small Cell Lung Cancer." Journal of the National Comprehensive Cancer Network 10, no. 10 (2012): 1236–71. http://dx.doi.org/10.6004/jnccn.2012.0130.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

48

Susman, Ed. "Advanced Small-Cell Lung Cancer." Oncology Times 36, no. 20 (2014): 26. http://dx.doi.org/10.1097/01.cot.0000456288.49614.66.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

49

Armstrong, J., B. Shank, H. Scher, et al. "Limited Small-Cell Lung Cancer." American Journal of Clinical Oncology 14, no. 4 (1991): 285–90. http://dx.doi.org/10.1097/00000421-199108000-00003.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

50

Von Eyben, F. E. "Treating small cell lung cancer." BMJ 305, no. 6844 (1992): 53. http://dx.doi.org/10.1136/bmj.305.6844.53.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!